Cardiotoxicity in a Patient with Multiple Relapses of Non-Hodgkin Lymphoma.
Exposure to different chemotherapeutic agents with cardiotoxic potential included in non-Hodgkin lymphoma treatment schemes can trigger myocardial injury by different mechanisms. Cardiooncology is a field that is emerging and working on new strategies for the diagnosis, prevention, and management of chemotherapy-induced cardiotoxicity.
Authors
- Horus Michael Virú Flores (ORCID: https://orcid.org/0000-0002-6685-9497)
- Brady Beltrán (ORCID: https://orcid.org/0000-0003-4469-3817)
- Juan Carlos Roque Quezada (ORCID: https://orcid.org/0000-0002-1886-0426)
- Joseph Alburqueque-Melgarejo (ORCID: https://orcid.org/0000-0002-8846-8884)
- L Villela
- L J Valverde-Graciano
Institutions
- Universidad Autónoma de Sinaloa (MX)
- Universidad de San Martín de Porres (PE)
- Universidad Científica del Sur (PE)
- Hospital de Emergencias Jose Casimiro Ulloa (PE)
- Institute for Social Security and Services for State Workers (MX)
Publication Details
- Journal
- PubMed
- Published
- 2024-12-30
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00